X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2907) 2907
Publication (284) 284
Newsletter (197) 197
Newspaper Article (40) 40
Book Chapter (25) 25
Book Review (23) 23
Magazine Article (14) 14
Book / eBook (8) 8
Web Resource (5) 5
Conference Proceeding (3) 3
Reference (2) 2
Dissertation (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1981) 1981
meningitis (1660) 1660
male (1210) 1210
index medicus (1075) 1075
adult (1015) 1015
female (960) 960
cryptococcal meningitis (931) 931
infectious diseases (761) 761
middle aged (710) 710
diagnosis (545) 545
hiv (497) 497
aids (489) 489
antifungal agents - therapeutic use (415) 415
microbiology (411) 411
infections (406) 406
aged (377) 377
mortality (370) 370
health aspects (366) 366
meningitis, cryptococcal - drug therapy (362) 362
cerebrospinal fluid (356) 356
research (352) 352
adolescent (331) 331
human immunodeficiency virus--hiv (331) 331
cryptococcosis (330) 330
meningitis, cryptococcal - diagnosis (319) 319
care and treatment (311) 311
immunology (311) 311
tuberculosis (308) 308
cryptococcus neoformans - isolation & purification (302) 302
fluconazole (297) 297
cryptococcus (294) 294
infection (293) 293
clinical neurology (286) 286
cryptococcus neoformans (284) 284
cerebrospinal-fluid (283) 283
disease (261) 261
risk factors (261) 261
amphotericin b - therapeutic use (256) 256
medicine, general & internal (253) 253
patients (253) 253
treatment outcome (240) 240
meningitis, cryptococcal - complications (233) 233
retrospective studies (233) 233
neoformans (225) 225
amphotericin-b (222) 222
epidemiology (220) 220
child (216) 216
hiv infections - complications (214) 214
meningitis, cryptococcal - microbiology (214) 214
animals (213) 213
diagnosis, differential (211) 211
magnetic resonance imaging (208) 208
medicine (206) 206
young adult (206) 206
cryptococcosis - drug therapy (201) 201
tuberculous meningitis (201) 201
neurosciences (200) 200
drug therapy (192) 192
medical research (185) 185
amphotericin b (184) 184
neurology (183) 183
cryptococcosis - diagnosis (182) 182
fluconazole - therapeutic use (180) 180
research article (180) 180
aids-related opportunistic infections - drug therapy (174) 174
central-nervous-system (173) 173
cerebrospinal fluid - microbiology (171) 171
antigens (169) 169
mycology (169) 169
meningitis, cryptococcal - cerebrospinal fluid (168) 168
acquired immune deficiency syndrome--aids (166) 166
management (164) 164
antiretroviral therapy (162) 162
hiv infection (160) 160
medicine, experimental (160) 160
analysis (157) 157
central nervous system (157) 157
therapy (153) 153
hiv patients (151) 151
antifungal agents (150) 150
aids-related opportunistic infections - microbiology (149) 149
nervous system (149) 149
adults (148) 148
encephalitis (147) 147
meningitis, cryptococcal - epidemiology (144) 144
meningitis - diagnosis (142) 142
cryptococcosis - microbiology (141) 141
acquired-immunodeficiency-syndrome (138) 138
medicine & public health (137) 137
hospitals (135) 135
flucytosine (134) 134
acquired immunodeficiency syndrome - complications (132) 132
prognosis (132) 132
drug therapy, combination (131) 131
aids-related opportunistic infections - diagnosis (127) 127
article (126) 126
cryptococcal infections (125) 125
mycoses (124) 124
internal medicine (123) 123
prospective studies (120) 120
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3027) 3027
French (49) 49
Spanish (34) 34
Japanese (30) 30
Chinese (11) 11
German (9) 9
Portuguese (8) 8
Korean (4) 4
Italian (2) 2
Norwegian (2) 2
Russian (2) 2
Turkish (2) 2
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 12, pp. 2126 - 2129
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 12, p. 2126
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4 <150 cells/mL underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence... 
Antigens | Therapy | Fungicides | Fluconazole | Viruses | Cerebrospinal fluid | Medical screening | CD4 antigen | Prescription drugs | Screening | Human immunodeficiency virus--HIV | Meningitis | Drug therapy | Drug dosages
Journal Article
AIDS, ISSN 0269-9370, 06/2012, Volume 26, Issue 9, pp. 1105 - 1113
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 9/2010, Volume 202, Issue 6, pp. 962 - 970
Background. Cryptococcal meningitis (CM)-related immune reconstitution inflammatory syndrome (IRIS) complicates antiretroviral therapy (ART) in 20%—40% of... 
Relapse | Cryptococcal meningitis | FUNGI | Cytokines | Dendritic cells | HIV | Antigen presenting cells | AIDS | Inflammation | Cerebrospinal fluid | Macrophages | INFECTIOUS DISEASES | ACTIVATION | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | IFN-GAMMA | MICROBIOLOGY | NEOFORMANS INFECTION | AMPHOTERICIN-B | IMMUNOLOGY | CASE-DEFINITION | ACTIVE ANTIRETROVIRAL THERAPY | EARLY MORTALITY | T-CELLS | Severity of Illness Index | Immune Reconstitution Inflammatory Syndrome - microbiology | Recurrence | Diagnosis, Differential | Cytokines - analysis | Humans | Cryptococcus neoformans - immunology | Acquired Immunodeficiency Syndrome - drug therapy | Cerebrospinal Fluid - immunology | Immune Reconstitution Inflammatory Syndrome - pathology | Meningitis, Cryptococcal - pathology | Cerebrospinal Fluid - chemistry | Inflammation Mediators - analysis | Cerebrospinal Fluid - microbiology | Acquired Immunodeficiency Syndrome - complications | Meningitis, Cryptococcal - immunology | Meningitis, Cryptococcal - complications | Antiviral agents | Care and treatment | Usage | Patient outcomes | Research | HIV (Viruses) | Complications and side effects | Physiological aspects | Diagnosis | Biological markers | Health aspects | cryptococcus neoformans | complications | Cryptococcal Meningitis | antiretroviral therapy | immune reconstitution inflammatory syndrome | Sub-Saharan Africa
Journal Article
Journal Article
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, ISSN 0317-1671, 2018, Volume 45, Issue 6, pp. 700 - 700
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 9/2009, Volume 49, Issue 5, pp. 702 - 709
Background. Progress in therapy for cryptococcal meningitis has been slow because of the lack of a suitable marker of treatment response. Previously, we... 
Antifungals | Health outcomes | Cryptococcal meningitis | Infectious diseases | Cytokines | HIV | Mortality | Articles and Commentaries | AIDS | Infections | Cerebrospinal fluid | INFECTIOUS DISEASES | RANDOMIZED-TRIAL | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | FUNGAL BURDEN | AMPHOTERICIN-B | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | UGANDA | PRESSURE | FLUCYTOSINE | FLUCONAZOLE | Prognosis | Prospective Studies | Meningitis, Cryptococcal - drug therapy | Humans | Male | Colony Count, Microbial | Thailand | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Dose-Response Relationship, Drug | Time Factors | AIDS-Related Opportunistic Infections - mortality | Adult | Female | Drug Therapy, Combination | Interferon-gamma - cerebrospinal fluid | Meningitis, Cryptococcal - cerebrospinal fluid | AIDS-Related Opportunistic Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Randomized Controlled Trials as Topic | AIDS-Related Opportunistic Infections - cerebrospinal fluid | South Africa | Uganda | Cerebrospinal Fluid - microbiology | Cohort Studies | Usage | HIV (Viruses) | Health aspects | Patient outcomes | Antifungal agents | Drugs | Infection | Fungicidal activity | Immunodeficiency | gamma -Interferon | Data processing | Meningitis | Statistics | Survival
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2013, Volume 56, Issue 8, pp. 1165 - 1173
Background. The burden of Cryptococcus neoformans in cerebrospinal fluid (CSF) predicts clinical outcomes in human immunodeficiency virus (HIV)—associated... 
HIV/AIDS | Antiretrovirals | Art therapy | Health outcomes | Cryptococcal meningitis | HIV | Mortality | AIDS | Random allocation | Cerebrospinal fluid | Arts | HIV-1 | highly active antiretroviral therapy (HAART) | cryptococcal meningitis | Africa | randomized controlled trial | INFECTIOUS DISEASES | RISK-FACTORS | EARLY FUNGICIDAL ACTIVITY | RANDOMIZED-TRIAL | MICROBIOLOGY | AMPHOTERICIN-B | IMMUNOLOGY | COMBINATION | HIGH-DOSE FLUCONAZOLE | RECONSTITUTION INFLAMMATORY SYNDROME | DISEASE | INFECTED PATIENTS | Meningitis, Cryptococcal - drug therapy | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Colony Count, Microbial | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Tenofovir | Deoxycytidine - therapeutic use | Adenine - therapeutic use | AIDS-Related Opportunistic Infections - mortality | Adult | Anti-HIV Agents - therapeutic use | Female | Immune Reconstitution Inflammatory Syndrome - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Meningitis, Cryptococcal - cerebrospinal fluid | AIDS-Related Opportunistic Infections - drug therapy | Treatment Outcome | Benzoxazines - therapeutic use | AIDS-Related Opportunistic Infections - cerebrospinal fluid | Survival Analysis | Amphotericin B - therapeutic use | Deoxycytidine - analogs & derivatives | Antiviral agents | Spine | Adults | Puncture | Drug therapy | Health aspects
Journal Article
The Lancet, ISSN 0140-6736, 05/2004, Volume 363, Issue 9423, pp. 1764 - 1767
It frequently takes more than 2 weeks for drug treatments for cryptococcal meningitis to sterilise cerebrospinal fluid (CSF). In-vitro and animal studies lend... 
ACQUIRED-IMMUNODEFICIENCY-SYNDROME | THAILAND | MEDICINE, GENERAL & INTERNAL | AIDS | AMPHOTERICIN-B | FLUCONAZOLE | Cryptococcus neoformans - isolation & purification | Flucytosine - administration & dosage | Meningitis, Cryptococcal - drug therapy | Meningitis, Cryptococcal - cerebrospinal fluid | Humans | AIDS-Related Opportunistic Infections - drug therapy | Fluconazole - administration & dosage | AIDS-Related Opportunistic Infections - diagnosis | Male | Colony Count, Microbial | Cerebrospinal Fluid - cytology | Meningitis, Cryptococcal - diagnosis | Meningitis, Cryptococcal - microbiology | Antigens, Fungal - cerebrospinal fluid | Cerebrospinal Fluid Pressure | AIDS-Related Opportunistic Infections - microbiology | AIDS-Related Opportunistic Infections - cerebrospinal fluid | Amphotericin B - administration & dosage | Adult | Female | Cerebrospinal Fluid - microbiology | Drug Therapy, Combination | Antifungal Agents - administration & dosage | Cryptococcal meningitis | Complications | Antifungal agents | Dosage and administration | Drug therapy | HIV infection | Risk factors | Fungi | Meningitis | Medical treatment | Human immunodeficiency virus--HIV | Therapy | Fungicides | Fluconazole | Laboratories | Mortality | Cryptococcosis | Cultures | Cerebrospinal fluid | Multivariate analysis | Patients | Clinical outcomes | Studies | Randomization | Tuberculosis | Fungicidal activity | Amphotericin B | Acquired immune deficiency syndrome--AIDS | Flucytosine
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 7, pp. 809 - 818
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 03/2017, Volume 75, Issue 3, pp. 299 - 307
Journal Article
PLoS Pathogens, ISSN 1553-7366, 05/2015, Volume 11, Issue 5, p. e1004884
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 01/2014, Volume 209, Issue 1, pp. 74 - 82
Journal Article